Source: Annual Congress 2013 –COPD biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Oda, C. Koga, S. Takenaka, T. Kawayama, T. Hoshino (Kurume, Japan). Positive association between the plasma levels of 5-hydroxyindoleacetic acid and the severity of depression in patients with chronic obstructive pulmonary disease. Eur Respir J 2013; 42: Suppl. 57, 2160

Member's Comments

No comment yet.

Related content which might interest you: Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Elevated sputum BPIFB1 levels correlate with progression of chronic obstructive pulmonary disease Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Changes in the level of melatonin in patients with varying degrees of severity of chronic obstructive pulmonary disease in conjunction with gastroesophageal reflux disease Source: International Congress 2014 – Comorbidities Year: 2014 Prevalence of anxiety and depression in 196 patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - COPD comorbidities I Year: 2012 Hyaluronic acid as a novel systemic biomarker to predict progression and severity in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Can HSP27 and HSP70 be used as biomarkers for chronic obstructive pulmonary disease diagnosis? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Relationship between pharmacotherapy and severity of disease in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 73s Year: 2007 Increased urinary l-histidine in patients with asthma–chronic obstructive pulmonary disease overlap Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Identification of oxidative stress markers and their association with inflammation in smokers and early chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Assessment of treatment efficiency in patients with chronic obstructive pulmonary disease combined with gastroesophageal reflux disease during treatment with melatonin Source: International Congress 2014 – Clinical presentations Year: 2014 Prognostic value of C-reactive protein in patients with severe to very severe chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006 Relationship between dyspnea and depression in the elderly patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD: points to ponder Year: 2014 Association between serum leptin, nutritional status and severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - COPD: from bench to bedside Year: 2008 Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 The prognostic importance of the protease-antiprotease imbalance in development of chronic obstructive pulmonary disease comorbid with chronic pancreatitis Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Serum lysophosphatidic acid levels and exacerbation frequency in chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung Year: 2020